Dr. Collinson has held a number of senior management roles at both Glaxo Wellcome and Aurora Biosciences. He has been a member of our Board of Directors since July 2001, following the merger of Vertex and Aurora Biosciences.
At Aurora, Dr. Collinson served as the President, Chief Executive Officer and Chairman of the Board. Dr. Collinson held senior management positions with Glaxo Wellcome from December 1994 to June 1998, most recently serving as Co-Chairman, Hospital and Critical Care Therapy Management Team and Director of Hospital and Critical Care. Dr. Collinson received his Ph.D. in physical chemistry from the University of Oxford, England and his M.B.A. from Harvard University. He currently serves as a Partner at Forward Ventures.